Delivery Order SPE2DB22D3301-SPE2DB24FY7DG
Award Date
5/21/24
Potential Completion Date
5/22/24
Potential Value
$6.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML pharmaceutical product. The $33,745.79 firm fixed price contract has an ultimate completion date of April 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00...
The Defense Logistics Agency (DLA) awarded a $10,542.44 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of Rebif 44 mcg/0.5 ml syringes. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which enables efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $20,046.74 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The delivery order is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product, with a completion date of January 31, 2024. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $15,587.92 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide REBIF 44 MCG/0.5 ML SYRINGE 0.5ML pharmaceutical products. This delivery order has a completion date of February 21, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to the Department of Defense through an...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is for the supply of the pharmaceutical product Rebif 44 mcg/0.5 mL syringe. The $4,131.04 firm fixed price delivery order has an ultimate completion date of August 19, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the United States, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,629.12 firm fixed-price delivery order is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $31,971.06 for the medical product REBIF 44 MCG/0.5 ML SYRINGE 0.5ML. The award has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 that serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a delivery order valued at $11,116.98 for the pharmaceutical product Rebif 44 mcg/0.5 ml syringe. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 25, 2021. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,540.37, is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. This is a delivery order contract, with a firm fixed-price pricing type, and an ultimate completion date of December 18, 2024. The contract does not have a set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product, with a firm fixed price ceiling value of $27,934.71 and a period of performance through April 1, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award, which is...